Skip to Content

Medipal Holdings Corp ADR MAHLY Stock Quote

| Rating as of


Last close prices updated as of May 30, 2023, 1:45 PM EST | USD
  • Last Close 15.79
  • Sector Healthcare
  • Industry Medical Distribution
  • Investment Style Mid Value
  • Day Range 15.79  –  15.79
  • Year Range 12.06  –  15.79
  • Market Cap 3.3143 Bil
  • Volume / Avg 535.0 /  290.2
  • Price / Sales 0.15
  • Price / Book 0.84
  • Forward Div Yield 2.19%
  • Trailing Div Yield 1.07%

Morningstar‘s Stock Analysis MAHLY

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics MAHLY

Company Profile MAHLY

Business Description

Medipal Holdings Corp distributes pharmaceuticals and health and beauty products to medical institutions and retailers. The firm operates in three segments: prescription pharmaceutical wholesale; cosmetics, daily necessities, and OTC pharmaceutical wholesale; and animal health products wholesale. The prescription pharmaceutical business generates the majority of revenue and distributes products to hospitals, clinics, and pharmacies. The cosmetics, daily necessities, and OTC pharmaceutical businesses distribute products to drugstores, convenience stores, and supermarkets. The animal health segment conducts wholesale business for animal hospitals, farms, and agricultural cooperatives. Medipal Holdings generates the vast majority of its revenue in Japan.

2-7-15, Yaesu, Chuo-ku
Tokyo, 104-8461, JPN
Industry Medical Distribution
Employees 20,485

Competitors & Peers MAHLY

Morningstar does not cover competitors or peers for this firm.

FAQs for Medipal Holdings Corp ADR Stock

Yes. MAHLY has a forward dividend yield of 1.07%. See MAHLY’s full dividends and stock split history on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

MAHLY’s market cap is 3.31 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

MAHLY’s stock style is Mid Value.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

MAHLY’s price/sales is 0.14.
Price/sales represents the amount an investor is willing to pay for a dollar generated from a particular company’s sales or revenues.

MAHLY’s price/forward earnings is 14.93.
Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates. The lower the Forward P/E, the cheaper the stock.

MAHLY’s price/book is 0.79.
Price/book ratio can tell investors approximately how much they’re paying for a company’s assets, based on historical, rather than current, valuations. Historical valuations generally do not reflect a company’s current market value. Value investors frequently look for companies that have low price/book ratios.

See MAHLY’s valuation ratios compared to the Market Index.

MAHLY’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare MAHLY’s historical performance against its industry peers and the overall market.